T. Rowe Price Associates »

Mirum Pharmaceuticals shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Mirum Pharmaceuticals (MIRM) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Mirum Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Mirum Pharmaceuticals held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mirum Pharmaceuticals by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2023-12-31 $34M 1.2M 29.52
2023-09-30 $1.0M 32k 31.62
2023-06-30 $2.6M 100k 25.87
2023-03-31 $287k 12k 24.06
2022-12-31 $328k 17k 19.49

More positions owned by T. Rowe Price Associates

Microsoft Corp Comm Stk (MSFT)
Apple Comm Stk (AAPL)
Amazon Comm Stk (AMZN)
Nvidia Corporation Comm Stk (NVDA)
Meta Platforms Comm Stk (META)
Alphabet Comm Stk (GOOGL)
Alphabet Comm Stk (GOOG)
Unitedhealth Group Comm Stk (UNH)
Eli Lilly & Co Comm Stk (LLY)
Visa Comm Stk (V)
Mastercard Incorporated Comm Stk (MA)
Tesla Comm Stk (TSLA)
Intuit Comm Stk (INTU)
Servicenow Comm Stk (NOW)
Fiserv Comm Stk (FI)

View all positions for T. Rowe Price Associates

Top funds holding Mirum Pharmaceuticals

Frazier Life Sciences Management
BVF
Eventide Asset Management
Vanguard Group
Henderson Group
Cadian Capital Management
Citadel Advisors
T. Rowe Price Associates
Avidity Partners Management
Tang Capital Management
Franklin Resources
First Turn Management
William Blair Investment Management
Perceptive Advisors
Boone Capital Management

View all funds holding Mirum Pharmaceuticals